RE: Cytiva expanding manufacturing capacity14 Sep 2020 08:23
This seems incredibly important news from our spit test partners .... and just look at the scale and reach of it!
Cytiva's long-term commitment is to deliver the best product, at the right time, and support our customers with expertise. The industry is growing rapidly, now even more due to COVID-19. Accelerating this investment will reinforce these commitments."
While the COVID-19 pandemic is increasing short-term demand, the biotherapeutics industry was already predicted to grow by double digits between now and 20251. Cytiva's global product manufacturing and distribution network encompasses 13 sites across Asia, the Americas, and Europe. The investments, totaling around 500 million USD, will respond to in-region, for-region demand, bolster security of supply through dual manufacturing, and increase overall global capacity in key product areas.